Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sube Banerjee

Showing results (181-190 of 214) with videos related to

Pageof 22
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 13, 2024
Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trialRobert Howard, Elizabeth Cort, Charlotte Rawlinson, et al.
BMJ Open|February 2, 2024
Clinical and cost-effectiveness of DREAMS START (Dementia RElAted Manual for Sleep; STrAtegies for RelaTives) for people living with dementia and their carers: a study protocol for a parallel multicentre randomised controlled trialPenny Rapaport, Sarah Amador, Mariam Adeleke, et al.
Health and Quality of Life Outcomes|April 18, 2026
Clinical, social, and home-level factors associated with the quality of life of residents living with dementia in Canadian nursing homes: a cross-sectional, multi-province studyGabriel J Dusing, Kyle Corbett, Emily Dymchuk, et al.
Alzheimer'S Research & Therapy|October 27, 2017
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
BMC Medicine|August 5, 2015
The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal?Perianayagam Arokiasamy, Uttamacharya Uttamacharya, Kshipra Jain, et al.
Alzheimer'S Research & Therapy|August 1, 2018
Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
The Lancet. Healthy Longevity|February 4, 2024
A psychosocial goal-setting and manualised support intervention for independence in dementia (NIDUS-Family) versus goal setting and routine care: a single-masked, phase 3, superiority, randomised controlled trialClaudia Cooper, Victoria Vickerstaff, Julie Barber, et al.
International Journal of Geriatric Psychiatry|February 3, 2023
Using digital technologies to facilitate social inclusion during the COVID-19 pandemic: Experiences of co-resident and non-co-resident family carers of people with dementia from DETERMIND-C19Ben Hicks, Kate Gridley, Josie Dixon, et al.
International Journal of Geriatric Psychiatry|February 23, 2018
A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025James Pickett, Cathy Bird, Clive Ballard, et al.
Lancet (London, England)|October 24, 2021
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trialSube Banerjee, Juliet High, Susan Stirling, et al.
Pageof 22

Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 13, 2024
Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trialRobert Howard, Elizabeth Cort, Charlotte Rawlinson, et al.
BMJ Open|February 2, 2024
Clinical and cost-effectiveness of DREAMS START (Dementia RElAted Manual for Sleep; STrAtegies for RelaTives) for people living with dementia and their carers: a study protocol for a parallel multicentre randomised controlled trialPenny Rapaport, Sarah Amador, Mariam Adeleke, et al.
Health and Quality of Life Outcomes|April 18, 2026
Clinical, social, and home-level factors associated with the quality of life of residents living with dementia in Canadian nursing homes: a cross-sectional, multi-province studyGabriel J Dusing, Kyle Corbett, Emily Dymchuk, et al.
Alzheimer'S Research & Therapy|October 27, 2017
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
BMC Medicine|August 5, 2015
The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal?Perianayagam Arokiasamy, Uttamacharya Uttamacharya, Kshipra Jain, et al.
Alzheimer'S Research & Therapy|August 1, 2018
Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
The Lancet. Healthy Longevity|February 4, 2024
A psychosocial goal-setting and manualised support intervention for independence in dementia (NIDUS-Family) versus goal setting and routine care: a single-masked, phase 3, superiority, randomised controlled trialClaudia Cooper, Victoria Vickerstaff, Julie Barber, et al.
International Journal of Geriatric Psychiatry|February 3, 2023
Using digital technologies to facilitate social inclusion during the COVID-19 pandemic: Experiences of co-resident and non-co-resident family carers of people with dementia from DETERMIND-C19Ben Hicks, Kate Gridley, Josie Dixon, et al.
International Journal of Geriatric Psychiatry|February 23, 2018
A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025James Pickett, Cathy Bird, Clive Ballard, et al.
Lancet (London, England)|October 24, 2021
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trialSube Banerjee, Juliet High, Susan Stirling, et al.
Pageof 22